312 related articles for article (PubMed ID: 8046951)
1. Antinociceptive effects of ketamine-opioid combinations in the mouse tail flick test.
Dambisya YM; Lee TL
Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):179-84. PubMed ID: 8046951
[TBL] [Abstract][Full Text] [Related]
2. Epidural ketamine potentiates epidural morphine but not fentanyl in acute nociception in rats.
Hoffmann VL; Baker AK; Vercauteren MP; Adriaensen HF; Meert TF
Eur J Pain; 2003; 7(2):121-30. PubMed ID: 12600793
[TBL] [Abstract][Full Text] [Related]
3. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
[TBL] [Abstract][Full Text] [Related]
4. Ketamine enhances the efficacy to and delays the development of tolerance to electroacupuncture-induced antinociception in rats.
Huang C; Long H; Shi YS; Han JS; Wan Y
Neurosci Lett; 2005 Feb; 375(2):138-42. PubMed ID: 15670657
[TBL] [Abstract][Full Text] [Related]
5. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin.
Kosson D; Klinowiecka A; Kosson P; Bonney I; Carr DB; Mayzner-Zawadzka E; Lipkowski AW
Eur J Pain; 2008 Jul; 12(5):611-6. PubMed ID: 18068383
[TBL] [Abstract][Full Text] [Related]
7. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay.
Baker AK; Hoffmann VL; Meert TF
Acta Anaesthesiol Belg; 2002; 53(3):203-12. PubMed ID: 12461830
[TBL] [Abstract][Full Text] [Related]
8. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
Cichewicz DL; Martin ZL; Smith FL; Welch SP
J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
[TBL] [Abstract][Full Text] [Related]
9. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
Edwards SR; Mather LE; Smith MT
Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
[TBL] [Abstract][Full Text] [Related]
10. Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine.
Fairbanks CA; Wilcox GL
J Pharmacol Exp Ther; 1999 Mar; 288(3):1107-16. PubMed ID: 10027848
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
13. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
Williams J; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
[TBL] [Abstract][Full Text] [Related]
14. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
15. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
16. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
17. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates.
Ossipov MH; Harris S; Lloyd P; Messineo E
J Pharmacol Exp Ther; 1990 Dec; 255(3):1107-16. PubMed ID: 2262895
[TBL] [Abstract][Full Text] [Related]
18. Modification of antinociceptive action of morphine by Ukrain in rodents.
Jagiełło-Wójtowicz E; Kleinrok Z; Chodkowska A; Feldo M; Nowicky JW
Drugs Exp Clin Res; 1992; 18 Suppl():101-5. PubMed ID: 1305035
[TBL] [Abstract][Full Text] [Related]
19. The effect of ciprofloxacin and gentamicin on spinal morphine-induced antinociception in rats.
Luger TJ; Farkas W; Geisler H; Lorenz IH
Basic Clin Pharmacol Toxicol; 2005 May; 96(5):366-74. PubMed ID: 15853929
[TBL] [Abstract][Full Text] [Related]
20. Potentiation by ketamine of fentanyl antinociception. I. An experimental study in rats showing that ketamine administered by non-spinal routes targets spinal cord antinociceptive systems.
Nadeson R; Tucker A; Bajunaki E; Goodchild CS
Br J Anaesth; 2002 May; 88(5):685-91. PubMed ID: 12067007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
